Biopharma and Population Products Director

• Define and own the product strategy, priorities, and roadmap for biopharma and population genomics offerings, balancing demonstrated market demand, operational feasibility, and commercial return.
• Develop and commercialize offerings for biopharmaceutical sponsors, including sponsored testing, patient identification for clinical trials, and testing solutions that support trial execution and monitoring.
• Build population screening programs for health systems, academic medical centers, and state programs, including appropriate reportable content for different populations.
• Own product definition from end to end, including clinical positioning, gene content, pricing, delivery workflows, turnaround-time commitments, and overall customer experience.
• Lead market and customer discovery with biopharmaceutical sponsors, health systems, patient organizations, and other strategic partners, translating insights into clear product requirements and decisions.
• Partner closely with Business Development on commercial execution, Medical Affairs on clinical and scientific positioning, and Laboratory Operations on capacity, workflow, and deliverability.
• Collaborate with Genomic Technology, Legal, and Compliance to ensure products are technically, operationally, and contractually deliverable, including appropriate data-use and consent provisions.
• Guide mature offerings into the core product portfolio when they evolve into catalog tests that can be ordered by treating clinicians.
• Build and maintain strategic partnerships with pharmaceutical companies, health systems, academic medical centers, public health programs, and other relevant organizations.
• Monitor product performance, market signals, and customer feedback to continuously refine offerings and support sustainable growth.
• Ensure product and program activities comply with organizational policies, procedures, and applicable regulatory requirements.

Requirements:

• Bachelor’s degree in life sciences, engineering, computer science, or a related discipline.
• At least 12 years of product or program management experience, including a minimum of 5 years developing genomic or diagnostic offerings for biopharmaceutical or population health buyers.
• At least 5 years of experience developing and commercializing data, software, informatics, genomic, or diagnostic products, with experience overseeing multiple functions or a significant organizational function.
• Demonstrated commercial success taking programs from initial definition through launch and revenue generation.
• Proven experience establishing contracts, partnerships, or commercial relationships with pharmaceutical sponsors, health systems, or public health programs.
• Working knowledge of clinical genomic testing, genomic reporting practices, and the related regulatory environment.
• Strong commercial judgment, including the ability to assess market opportunities, size potential, and clearly defend commercial assumptions.
• Ability to define products that successfully balance the needs of buyers, clinicians, laboratories, and other stakeholders.
• Strong external presence and credibility when engaging clinical and scientific leaders at academic institutions, pharmaceutical companies, and other strategic organizations.
• Demonstrated ability to influence cross-functional teams without direct authority across commercial, medical, technology, laboratory, legal, and compliance functions.
• Comfortable operating in ambiguous environments and turning early customer interest into clearly defined, deliverable offerings.
• An advanced degree in genetics, genomics, public health, or a related discipline is preferred; board-certified genetic counselor experience is also favorably considered.
• Experience in rare disease, newborn screening, population genomics, clinical trial operations, patient recruitment, companion diagnostics, or state/federal public health programs is preferred.

Benefits:

• Competitive senior-level opportunity with ownership of strategic product development and commercialization.
• Remote work within the United States.
• Meaningful autonomy to define product strategy, roadmap, pricing, delivery models, and market priorities.
• Cross-functional leadership exposure across commercial, medical, laboratory, technology, legal, and compliance teams.
• Strategic external engagement with biopharmaceutical sponsors, health systems, academic medical centers, patient organizations, and public health programs.
• Travel: Approximately 20–30% travel for sponsor and health system engagements, conferences, and periodic work in Houston.
• Flexible collaboration: Occasional work outside standard hours may be required to accommodate partners across different time zones.
• Mission-driven impact: Opportunity to contribute to the broader adoption of whole genome sequencing through innovative biopharma and population health solutions.
• Work environment: Primarily home-office based, with prolonged computer and video conference work and no laboratory exposure or lifting requirements beyond normal office equipment.
• Inclusive workplace: Commitment to equal employment opportunity and an inclusive environment for employees from diverse backgrounds.